Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Kewaunee Scientific VP sells $109,725 in company stock

Published 03/18/2024, 04:12 PM
Updated 03/18/2024, 04:12 PM
© Reuters.

In a recent transaction on March 15, Kewaunee Scientific Corp's (NASDAQ:KEQU) Vice President of Manufacturing Operations, Douglas J. Batdorff, sold 3,500 shares of the company's common stock at a price of $31.35 per share, totaling $109,725. Following the sale, Batdorff's direct holdings in Kewaunee Scientific Corp now amount to 6,167 shares.

This sale is part of the regular financial disclosures that executives of publicly traded companies are required to make. The sale was executed directly and reflects a transaction that could be of interest to investors and followers of Kewaunee Scientific's stock.

Kewaunee Scientific Corp, with its headquarters in Statesville, North Carolina, specializes in laboratory apparatus and furniture, serving various industries with its products. The company is known for its commitment to quality and innovation in the scientific community.

Investors often monitor the buying and selling activities of company insiders as it can provide insights into their perspective on the company's current valuation and future prospects. However, it is important to note that there are many reasons why an executive might decide to sell shares, and such transactions do not necessarily reflect a negative outlook on the company's future performance.

The details of the transaction have been made public as part of the regulatory filings with the Securities and Exchange Commission, which maintains transparency and allows investors to stay informed about significant trades made by company insiders.

InvestingPro Insights

As Kewaunee Scientific Corp (NASDAQ:KEQU) continues to make headlines with insider trading activity, investors are taking a closer look at the company's financial health and market performance. According to recent data from InvestingPro, Kewaunee Scientific Corp boasts a market capitalization of approximately $92 million USD, with a noteworthy P/E ratio of 10.53, reflecting the company's earnings over the last twelve months as of Q3 2024. Despite a challenging environment with a revenue decline of 6.59% over the same period, the company has demonstrated a robust gross profit margin of 23.76%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

An InvestingPro Tip highlights that Kewaunee Scientific Corp's valuation implies a strong free cash flow yield, which could be an attractive point for investors seeking companies with potential for healthy cash generation relative to their share price. Additionally, the company's performance has been strong over the past year, with a price total return of 95.53%, and it's trading near its 52-week high at 98.62% of the peak price.

For investors intrigued by these metrics and seeking more detailed analysis, there are 9 additional InvestingPro Tips available for Kewaunee Scientific Corp, which can be accessed by visiting https://www.investing.com/pro/KEQU. Interested readers can also take advantage of a special offer using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, providing deeper insights that could inform investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.